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Abstract: Objective: To investigate the effects and mechanism of Tusi Erxian Decoction in treating asthenospermia 
with syndrome of deficiency of kidney yang. Methods: A total of 180 patients were included and randomly divided into 3 groups: 
Tusi Erxian Decoction group, Yougui Pills group, and the western medicine group (coenzyme Q10 capsule, vitamin E and vitamin 
C), 60 cases per group. Each group was treated by the corresponding drugs for 3 months. The sperm parameters, malondialdehyde 
(MDA) and superoxide dismutase (SOD) were detected to compare the clinical efficacy. Results: The Tusi Erxian Decoction 
could significantly improve a-level sperm, sperm motility and sperm activity when compared with the Yougui Pills group and 
the western medicine group (P<0.01). Meanwhile, Tusi Erxian Decoction could decrease the concentration of MDA and increase 
SOD in the seminal plasma (P<0.01). Clinical efficacy in the Tusi Erxian Decoction group was significantly better than that in the 
Yougui Pills group and the western medicine group (P<0.05). Conclusion: Tusi Erxian Decoction can improve the quality of sperm 
of asthenospermia patients with syndrome of deficiency of kidney yang by enhancing the antioxidant activity of spermatozoa.
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Superoxide dismutase
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表2 各组患者治疗前后精浆MDA和SOD的比较（x-±s）
组别 例数  时间 MDA（nmoL/mL） SOD（U/mL）
菟丝二仙汤组 58 治疗前 13.58±2.13 102.51±4.94
治疗后 9.30±2.02** 166.68±6.68**
右归丸组 57 治疗前 13.69±2.02 105.54±5.14
治疗后 10.79±2.12**△△ 143.81±2.59**△△
西药组 57 治疗前 13.81±2.13 103.59±5.15
治疗后 11.75±2.16**△△ 123.48±3.92**△△
表3  各组患者临床疗效比较（例）
组别 例数 痊愈 显效 有效 无效 总有效率（%）
菟丝二仙汤组 58 10 27 12 9 84.5
右归丸组 57 6 16 13 22  61.4**
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组别 例数  时间 精子密度（×106/mL） a级精子比例（%） a+b级精子比例（%） 精子活率a+b+c（%）
菟丝二仙汤组 58 治疗前 31.06±12.65 11.85±4.12 26.55±7.69 36.72±7.42
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摘要：目的：初步评价温胆颗粒对替诺福韦（TDF）药代动力学影响作用。方法：温胆颗粒治疗2周，
留取治疗前后患者血浆标本，进行TDF药物药代动力学检测并进行分析。结果：温胆颗粒治疗前后TDF血浆
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